Collectively, our findings uncovered the biological function and underlying mechanism of a newly identified lncRNA, UPK1A-AS1, which promotes HCC progression partially dependent on EZH2 by accelerating the cell cycle G1/S transition. This evidence concerns the gene EZH2 and hepatocellular carcinoma.